Precigen
PGEN
$1.41
Share price
0.71%
Change (1 day)
16.53%
Change (1 year)
Categories
Precigen (PGEN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $32.54 M
According to Precigen's latest financial reports the company's total liabilities are $32.54 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Precigen - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $89.71 M | -64.47% |
| 2021-12-31 | $0.25 B | 2.06% |
| 2020-12-31 | $0.24 B | -35.58% |
| 2019-12-31 | $0.38 B | 13.81% |
| 2018-12-31 | $0.33 B | 12.37% |
| 2017-12-31 | $0.30 B | -20.93% |
| 2016-12-31 | $0.37 B | 37.04% |
| 2015-12-31 | $0.27 B | 65.98% |
| 2014-12-31 | $0.16 B | 89.48% |
| 2013-12-31 | $88.12 M | -81.38% |
| 2012-12-31 | $0.47 B | 40.8% |
| 2011-12-31 | $0.33 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.69 M | -91.71% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 274.89% | 🇬🇧 UK |
 Novavax NVAX | $2.51 B | 7,625.98% | 🇺🇸 USA |
 Novocure
NVCR | $0.78 B | 2,307.84% | Jersey |